Serum antibody to Sarcoptes scabiei and house dust mite prior to and during infestation with S. scabiei.
In this study, serum antibodies to Sarcoptes scabiei var. canis (SS), Dermatophagoides farinae (DF), and D. pteronyssinus (DP) were determined in 19 healthy, random-source dogs prior to infestation with scabies then again during a primary infestation, cure and challenge infestation with scabies. Prior to scabies infestation, serum of 11 dogs contained faintly detectable amounts of IgE and/or IgG to proteins in SS extract, probably resulting from sensitization to dust mites that share cross-reactive antigenic epitopes with SS. After becoming infested with scabies, the response to SS antigens became stronger with antibodies appearing to more antigens as the scabies infestation progressed. Three of the newly recognized proteins were 170, 155 and 142/133kD and could be used in a diagnostic test since antibodies to them appeared during the primary infestation. In addition, during the primary infestation, 14 of 15 dogs developed IgE to 1-11 new SS proteins in addition to an increase in IgE binding to those proteins recognized prior to infestation. Overall, the strongest antibody responses (IgE and IgG) were exhibited during cure of the first infestation, when dead mites were still present in the stratum corneum. As expected, the antibody response was strong and rapid during challenge when the infestation self-cured. The immunogenic SS proteins identified by serum antibody binding during challenge, when the hosts self-cured, are candidates for inclusion in a vaccine. These candidate proteins are 200, 185, 170, 155, 142/133, 112, 97, 74, 57, 45/42, 32 and 22kD. Some of the proteins in SS that exhibited new or increased antibody binding during the experiment also had IgE and IgG binding to proteins with similar molecular weights in DF and DP extracts. These results illustrate the difficulties involved in understanding and interpreting serum antibody for developing a serological test for the diagnosis of scabies, isolating relevant SS antigens that could be included in a vaccine for prevention of scabies, and for understanding the immune response mechanism to scabies.
Arlian
L G
LG
Department of Biological Sciences, Wright State University, Dayton, OH 45435, USA. larry.arlian@wright.edu
Morgan
M S
MS
D000818:Animals; D015153:Blotting, Western / Q000662:veterinary; D004283:Dog Diseases / Q000276:immunology* / Q000469:parasitology; D004285:Dogs; D004391:Dust / Q000009:adverse effects; D004591:Electrophoresis, Polyacrylamide Gel / Q000662:veterinary; D005260:Female; D007091:Image Processing, Computer-Assisted; D007073:Immunoglobulin E / Q000097:blood*; D007074:Immunoglobulin G / Q000097:blood*; D007306:Insecticides / Q000627:therapeutic use; D007559:Ivermectin / Q000627:therapeutic use; D008297:Male; D008924:Mite Infestations / Q000662:veterinary; D008925:Mites / Q000276:immunology*; D012520:Sarcoptes scabiei / Q000276:immunology* / Q000469:parasitology; D012532:Scabies / Q000276:immunology / Q000469:parasitology / Q000517:prevention & control / Q000662:veterinary*
D004391:Dust; D007074:Immunoglobulin G; D007306:Insecticides; D007073:Immunoglobulin E; D007559:Ivermectin